ECSTACY: A Review of MDMA and MDA
- 1 December 1987
- journal article
- review article
- Published by SAGE Publications in The International Journal of Psychiatry in Medicine
- Vol. 16 (4), 359-372
- https://doi.org/10.2190/dcrp-u22m-aumd-d84h
Abstract
The Drug Enforcement Administration classified the drug methylenedioxymeth-amphetamine, MDMA, also known as Ecstacy, as a Schedule I controlled substance on July 1, 1985. The controversy surrounding the classification of MDMA is related to the question of its efficacy as an adjunct to psychotherapy and the larger issue of how to regulate the production and use of designer drugs. The authors review the literature on MDMA and its predecessor, MDA, a substance that differs from MDMA by one methyl group.Keywords
This publication has 47 references indexed in Scilit:
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve TerminalsScience, 1985
- MethylenedioxyamphetamineArchives of Internal Medicine, 1981
- The inhibition of food intake in the dog by LSD, mescaline, psilocin, -amphetamine and phenylisopropylamine derivativesLife Sciences, 1979
- 3,4-Methylenedioxyamphetamine OverdoseClinical Toxicology, 1979
- Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine AdministrationScience, 1978
- Metabolism of β-3,4-methylenedioxyamphetamine in the ratBiochemical Pharmacology, 1978
- The Properties of 3,4-Methylenedioxyamphetamine (MDA). II. Studies of Acute Toxicity in the Mouse and Protection by Various AgentsClinical Toxicology, 1973
- A Fatal Case Involving MethylenedioxyamphetamineClinical Toxicology, 1972
- Incidents Involving the Haight-Ashbury Population and Some Uncommonly Used DrugsJournal of Psychedelic Drugs, 1968
- Psychopharmacological Activity of Ring- and Side Chain-Substituted β-Phenethylamines1The Journal of Organic Chemistry, 1958